Good news for breast Ca survivors who want to become pregnant

Article

Women with localized breast cancer who have a good prognosis may attempt pregnancy as soon as 6 months after completing treatment, rather than the oft recommended 2 years, without negatively influencing maternal survival, according to the results of a recent population-based study.

Women with localized breast cancer who have a good prognosis may attempt pregnancy as soon as 6 months after completing treatment, rather than the oft recommended 2 years, without negatively influencing maternal survival, according to the results of a recent population-based study.

Researchers from Australia found that women who subsequently conceived had higher overall survival rates than those who didn't (hazard ratio 0.59, 95% CI, 0.37–0.95). While the effect was nonsignificant in those women who waited at least 6 months after completing treatment to conceive, it was significant in those who waited at least 24 months (0.48, 0.27–0.83).

Ives A, Saunders C, Bulsara M, et al. Pregnancy after breast cancer: population-based study. BMJ. 2007;334:194-196.

Recent Videos
Baher Mankabady, MD, highlights safety of buprenorphine against OUD in pregnancy | Image Credit: linkedin.com.
Devon Ramaeker, MD
Elizabeth Gandee, APRN-CNP, highlights gaps in women's menopause knowledge | Image Credit: wexnermedical.osu.edu
Doula highlights how postpartum care is failing new mothers | Image Credit: linkedin.com
Nicky Herrick MD; and Anushree Agarwal, MD, MBBS, highlight their study on cardiac arrhythmias in pregnancy | Image Credit: © Igor Borodin - stock.adobe.com.
Lisa Becht, MD, FACOG, sheds light on fertility awareness | Image Credit: havingbabies.com.
First US national HPV conference highlights advances in cancer prevention | Image Credit: uchealth.com.
Mitchell Creinin, MD, reports estetrol pill eases menstrual symptoms | Image Credit: health.ucdavis.edu
1 expert is featured in this series.
Susanna Mitro, PhD, reveals ethnic disparities in uterine fibroid diagnosis | Image Credit: divisionofresearch.kaiserpermanente.org.
Related Content
© 2025 MJH Life Sciences

All rights reserved.